Cite
Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019.
MLA
Chan, Gordon Chun Kau, et al. “Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019.” Clinical Infectious Diseases, vol. 77, no. 10, Nov. 2023, pp. 1406–12. EBSCOhost, https://doi.org/10.1093/cid/ciad371.
APA
Chan, G. C. K., Lui, G. C. Y., Wong, C. N. S., Yip, S. S. T., Li, T. C. M., Cheung, C. S. K., Sze, R. K. H., Szeto, C. C., & Chow, K. M. (2023). Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019. Clinical Infectious Diseases, 77(10), 1406–1412. https://doi.org/10.1093/cid/ciad371
Chicago
Chan, Gordon Chun Kau, Grace Chung Yan Lui, Candy Ngai Sze Wong, Sindy Sin Ting Yip, Timothy Chun Man Li, Catherine Siu King Cheung, Ryan Kin Ho Sze, Cheuk Chun Szeto, and Kai Ming Chow. 2023. “Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019.” Clinical Infectious Diseases 77 (10): 1406–12. doi:10.1093/cid/ciad371.